SC pharma company rebuked by FDA after marketing drug as COVID-19 symptom treatment
https://www.postandcourier.com/business/sc-pharma-company-rebuked-by-fda-after-marketing-drug-as-covid-19-symptom-treatment/article_3cbac9be-070a-11eb-bb8a-231b779ad792.html
SC pharma company rebuked by FDA after marketing drug as COVID-19 symptom treatment
By Jessica Holdman
Oct 5, 2020 Updated 15 hrs ago
WEST COLUMBIA Nephron Pharmaceuticals is in trouble with federal regulators after its chief executive shared emails last month that pitched a childrens asthma drug as a possible treatment for COVID-19 symptoms.
The U.S. Food and Drug Administration sent a warning letter dated Sept. 22 to the West Columbia generic drugmaker, threatening regulatory action if it did not cease any marketing materials that give a misleading impression about the safety and effectiveness of Budesonide for the treatment of COVID-19.
We are working diligently with FDA to resolve the matter and have no further comment at this time, Nephron CEO Lou Kennedy said in a statement.
[...]